Eton Pharmaceuticals, Inc. Development Agreements
4 Contracts & Agreements
- Development, Supply and Commercialization Agreement (CT-100) dated November 7, 2017 between Amphastar Pharmaceuticals, Inc. and the Registrant (Filed With SEC on October 18, 2018)
- Development, Supply and Commercialization Agreement (CT-100) dated November 7, 2017 (Filed With SEC on September 25, 2018)
- Development, Supply and Commercialization Agreement (CT-100) dated November 7, 2017 (Filed With SEC on August 10, 2018)
- Exclusive Development and Supply Agreement (DS-100) dated July 9, 2017 between Andersen Pharma, LLC and the Registrant (Filed With SEC on August 10, 2018)
